REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
6.93
-0.24 (-3.28%)
At close: Oct 16, 2026, 4:00 PM EDT
6.95
+0.03 (0.36%)
After-hours: Oct 16, 2026, 7:30 PM EDT
REGENXBIO Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, REGENXBIO stock has a consensus rating of "Buy" and an average price target of $23.58. The average 1-year stock price forecast is 240.51% higher than the current stock price, while the lowest is $10 (+44.40%) and the highest is $50 (+622.02%).
Price Target: $23.58 (+240.51%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for REGENXBIO stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 7 |
| Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Maintains $19 | Buy | Maintains | $19 | +174.37% | Oct 13, 2026 |
| Barclays | Barclays | Hold Maintains $12 | Hold | Maintains | $12 | +73.29% | Oct 13, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Initiates $22 | Buy | Initiates | $22 | +217.69% | Oct 5, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $42 | Buy | Reiterates | $42 | +506.50% | Sep 25, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $21 | Buy | Reiterates | $21 | +203.25% | Sep 25, 2026 |
Financial Forecast
Revenue This Year
163.72M
from 170.44M
Decreased by -3.95%
Revenue Next Year
200.42M
from 163.72M
Increased by 22.42%
EPS This Year
-3.49
from -3.76
EPS Next Year
-2.98
from -3.49
EPS and Forward PE are based on non-GAAP adjusted numbers.